-
QNET DENIES ANY ASSOCIATION WITH IGNITE
HYDERABAD, India, June 13, 2026 /PRNewswire/ — QNET has taken note of recent media reports published in Telangana concerning the alleged activities of an entity operating under the name IGNITE, as well as references that seek to associate those activities with QNET and its franchisee in India, Vihaan Direct Selling (India) Pvt. Ltd. Given the…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions
WASHINGTON, June 12, 2026 /PRNewswire/ — ELIQUENT Life Sciences (“ELIQUENT”) today announced the June 1 go-live of Veeva Safety Suite at UCB. As one of the first organizations to adopt the complete suite, UCB is unifying its global safety operations in a transformation delivered through a strategic collaboration between Veeva, ELIQUENT, Pinnaxis, and Daelight Solutions.…
-
Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health
Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. NORWALK, Conn., June 11, 2026 /PRNewswire/ — Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate Bio on the successful close of a $6 million financing round and…
-
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, June 10, 2026 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), announced today that its shareholders voted in favour of all items of business brought before them at the Company’s annual and…
-
Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals’ Caffinity™
MOMENCE, Ill., June 10, 2026 /PRNewswire/ — FutureCeuticals, Inc. is pleased to announce the peer-reviewed publication of clinical research demonstrating unique energy, performance, and metabolic benefits of Caffinity™, a proprietary ingredient derived from the Arabica coffee cherry (bean and fruit). This study, conducted by recognized experts in energy metabolism at the University of Exeter (UK), establishes…
-
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
June 09, 2026 19:00 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance…
-
Huawei Launches the “AHEAD” Program to Build a New Ecosystem for Mutual Benefits in Education and Healthcare
SHENZHEN, China, June 9, 2026 /PRNewswire/ — The 2026 Global Education & Healthcare Partners Convention, convened under the theme “Together, Enabling Intelligent-led Education & Healthcare,” successfully concluded in China. The event drew over 500 industry customers and partners across more than 40 countries and regions. At the event, Huawei unveiled the Alliance on Healthcare &…
-
Not Just Pharmacy: How Medkart is Building India's Smartest Generic Medicine App
Ahmedabad, Gujarat, India India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world’s largest medicine markets, millions of Indian families continue to struggle with the high cost of treatment. Studies show that over 50% of healthcare expenses in India are still paid out-of-pocket, leaving many to either delay care…
-
Medkart Champions Generic Drug Quality Amid Rising Consumer Concerns
Ahmedabad, Gujarat, India With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat’s largest generic-first pharmacy chain, is stepping forward to assure patients that affordability does not mean compromise. In response to increasing consumer concerns, the company has reinforced its Medkart Assured program—rooted in audit-based sourcing, Schedule M compliance, and…
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas June 07, 2026 19:41 ET | Source: GNI Group Co., Ltd. TOKYO, June 07, 2026 (GLOBE NEWSWIRE) — GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
IFQM Symposium 2025 Concludes with a Call for Quality & Innovation to Make India Globally Competitive
New Delhi, Delhi, India India is at the cusp of developing and making products for the world, with quality that is of international standards, especially in the electronics and semiconductor industry, and MSMEs and startups have huge potential. It is not a distant ambition but a fast-emerging reality, but does India have the hunger to…
-
This Pharmacy Chain is Saving India INR 300 Cr a Year – And You've Probably Never Heard of It
In India’s complex and expensive healthcare ecosystem, where sufferers still consume a significant portion of their income on pharmaceuticals, a quiet transformation is ongoing. While digital health startups often lead headlines, one drugstore chain is leading a hidden but impactful transformation. Medkart, based in Gujarat and focused solely on generic medicines, is helping Indian households…
-
Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews
Editorial note: This article is an independent informational evaluation of publicly available product information. It is not medical advice, not a diagnosis or treatment recommendation, and not an endorsement of any brand. Dietary supplements are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, including menopause. Statements have not…
-
SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects
Mumbai, Maharashtra, India Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1. Despite advances in medical care, CHD continues to be a leading cause of infant and child mortality, highlighting the need for…
-
MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub to Improve Access to GLP-1 and Critical Care Medicines
MrMed, India’s largest online super-specialty pharmacy, has opened a state-of-the-art cold-chain distribution hub in Bengaluru. The new facility strengthens the company’s ability to deliver temperature-sensitive medicines especially GLP-1 therapies quickly and safely across South India. MrMed Bengaluru Hub As diabetes and obesity continue to rise at an alarming rate, with over 100 million people in…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
-
Zuellig Pharma Unveils State-of-the-art Clinical Trial Support Innovation Center in South Korea to Support both Domestic and Global Clinical Research Needs
Gyeonggi-Do, South Korea Zuellig Pharma, a leading healthcare solutions company in Asia, today announced the grand opening of its new state-of-the-art Clinical Trial Support (CTS) Innovation Center in South Korea. The opening of this facility underscores Zuellig Pharma’s continued investment and commitment to advancing healthcare, reinforcing its position as a trusted regional partner in driving…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry Applications Summit in Beijing, where it showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health. The conference, themed “Agent…
-
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels June 05, 2026 02:00 ET | Source: Chiesi Global Rare Diseases PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a…
-
Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics
New Frost & Sullivan White Paper Highlights Emerging Opportunities Across Healthy Aging, Functional Nutrition, Personal Care, and Preventive Healthcare SHANGHAI, June 4, 2026 /PRNewswire/ — Frost & Sullivan’s latest white paper, Global Ergothioneine Industry Current Landscape and Development Trends, reveals that ergothioneine (EGT) is rapidly transitioning from a niche antioxidant ingredient into a scalable, science-backed platform for…
-
Havih, a Maxwell Biosciences Subsidiary, Announces Partnership with the Government of Andhra Pradesh
This partnership will establish a new research and production facility in Andhra Pradesh, driving India’s transition toward pharmaceutical leadership and creating high-tech jobs Pulivendula, Andhra Pradesh, India Havih Envirosciences, an Indian citizen-owned and operated life sciences company and subsidiary of Maxwell Biosciences, announced a strategic partnership with the Government of Andhra Pradesh to establish advanced…
-
Anderson Diagnostics and MAHE Launch Groundbreaking Centre of Excellence in Reproductive Genomics
MAHE-Anderson COE to Revolutionise Women’s Healthcare Diagnostics Manipal, Karnataka, India; Chennai, Tamil Nadu, India Anderson Diagnostics & Labs, Chennai, in a landmark partnership with Manipal Academy of Higher Education (MAHE), today announced the formal launch of the MAHE-Anderson Centre of Excellence (COE) in Reproductive Genomics. Inaugural Ceremony of Centre of Excellence in Reproductive Genomics…
-
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches 2026 global employee stock purchase plan Paris, June 4, 2026. Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Gujarat becomes the New Hub in Organ Transplantation
Zydus Hospitals Ahmedabad and Vadodara reach new heights in advanced transplant care AHMEDABAD, India, June 4, 2026 /PRNewswire/ — Organ transplantation in India has come a long way over the past five decades, and Gujarat has been significantly contributing to this milestone, with Zydus Hospitals at its forefront. Across its centres in Ahmedabad and Vadodara, Zydus Hospitals has…
-
World Regional Anaesthesia and Pain Medicine day Workshop brings the Spotlight on Strengthening Patient Safety Standards
New Delhi, Delhi, India BD (Becton, Dickinson and Company) recently participated as Knowledge Partner at the World Regional Anaesthesia & Pain Medicine (RAPM) Day Workshop. With the objective of reinforcing patient-safety practices in Regional Anaesthesia, BD India/South Asia focused on enabling real-time, hands-on learning for clinicians to advanced spinal anaesthesia solutions and supporting faculty-led live…
-
Kapiva Launches Rs. 50 Crore Innovation Fund to Build Evidence-Based, Future-Ready Ayurveda Ecosystem
Bengaluru, Karnataka, India Kapiva, India’s first modern holistic Ayurvedic brand for millennials, today announced the launch of the Kapiva Innovation Fund (“KIF”), a commitment of up to Rs. 50 crore to support research and innovation in Ayurveda. KIF will back projects across academia, labs and startups that focus on R&D in Ayurvedic science and create…
-
It’s Not a Prenatal Class, It’s a Social Club With a Curriculum for Parenthood — Launching in Miami This August
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) — Miami has attracted transplants, globally mobile families, and ambitious young professionals who are building lives far from the support systems they grew up with. At the same time, lifelong Miami families are navigating parenthood in a city that can often feel fast-paced, disconnected, and isolating during one of…
-
Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor
Pioneering Physician and Interventional Pulmonology Innovator Joins Noah Medical to Accelerate the Next Era of Robotic-Assisted Lung Cancer Diagnosis and Treatment June 03, 2026 08:00 ET | Source: Noah Medical SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) — Noah Medical, a medical robotics company dedicated to earlier, more accurate lung cancer diagnosis, announced the…
-
HBSUK and Hexaware partner to enhance clinician onboarding efficiency
MUMBAI, India, ISELIN, N.J. and LONDON, June 3, 2026 /PRNewswire/ — HBSUK, a UK-based healthcare services provider, and Hexaware Technologies (NSE: HEXT), a global IT services and solutions provider, have announced a strategic collaboration to enhance HBSUK’s workforce management proposition. With around 7.22 million people currently awaiting treatment within the NHS, healthcare providers face growing…
-
Morepen Bags Rs. 825 Crore Global Deal
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major. Morepen Bags Rs. 825 Crore Global Deal, Expands into High-Growth CDMO Segment Supplies under the mandate are expected to commence within the…
-
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26. Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The…
-
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. June 02, 2026 10:05 ET | Source: Jersey College TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) — Jersey College, the institution dedicated to excellence in nursing education, provides an Associate Degree in Nursing program at its Teterboro and Ewing, N.J., campuses, offering…
-
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four decades of MAPS advocacy by turning the lens of psychedelic research toward people directly harmed by the war on drugs MAPS…
-
Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2, 2026 /PRNewswire/ — As laboratories increasingly seek faster, more cost-efficient alternatives to legacy single-analyte testing, demand for scalable multi-analyte proteomic workflows is…
-
Raay Neo Pharma Launches to Transform India's Healthcare Landscape with Quality-Driven, Patient-Centric Pharmaceutical Solutions
Mumbai, Maharashtra, India Raay Neo Pharma, a next-generation pharmaceutical company, has officially unveiled its operations with the aim to contribute to quality healthcare for all Indians. Founded using a flexible and scalable operational framework and supported by more than five decades of diverse entrepreneurial success, Raay Neo Pharma will be introducing its range of more…
-
Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time
Company sets a benchmark again in pharmaceutical excellence reinforcing its global leadership in quality and regulatory compliance Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, with Zero adverse observations (No Form 483 issued…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
Acquisition supports Servier’s strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of up to $2.65 billion. SURESNES, France, June 1, 2026 /PRNewswire/ — Servier, an independent international pharmaceutical group governed by a foundation, today announced that…
-
Platinum Industries Announces Entry into Life Sciences; Collaborates with Dr. Abhigyan Upadhyay to Lead the New Enterprise, Rivadu Lifesciences Pvt. Ltd.
Strengthens leadership to build a research-driven and globally scalable model in high-value life sciences segments Mumbai, Maharashtra, India Platinum Industries Ltd. [NSE: PLATIND; BSE: 544134], an innovation-driven specialty chemicals company announced its strategic entry into the life sciences sector, marking a significant step in its next phase of growth. As part of this expansion, the…
-
Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Dividend
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), announced its financial results for the fourth quarter and the full year ended March 31, 2026. The company delivered a steady performance during Q4 FY26, with healthy revenue growth and improved operating profitability driven by its core domestic…
-
Niche Group Advances India's Vision Across Organic Farming and Cancer Treatment
At the same time, he revealed that Niche Agriculture and Pharmaceuticals Limited (NAPL) is working on affordable medicines for diseases such as cancer, epilepsy, and Alzheimer’s. Hundreds of PhD scholars were also interviewed and selected for opportunities during the event. Nestled amidst the beauty of nature, the auditorium of CSKHPKV transformed into far more than…
-
Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26
Gurugram, Haryana, India Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. Revenue growth during the quarter was supported by export momentum and expansion in the Medical Devices business, while operational momentum strengthened toward the latter…
-
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLC Plasma MET test showed high concordance with tissue IHC/FISH in EGFR-mutated NSCLC following progression on first-line targeted therapy (AUC=0.97) Baseline and longitudinal profiling in METex14 skipping NSCLC identified biology associated with therapeutic…
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR…
-
World MS Day: National Policy Dialogue Adopts Landmark 10-Point Declaration Calling for Stronger Recognition of Invisible Disabilities in India
~Stakeholders urge reforms across disability certification, healthcare access, insurance, workplace inclusion and national health systems to improve outcomes for people living with Multiple Sclerosis and other invisible neurological conditions~ NEW DELHI, May 30, 2026 /PRNewswire/ — In a significant step towards strengthening disability-inclusive healthcare and social protection in India, Members of Parliament, policymakers, neurologists, disability…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.